Laxxon has both an external pipeline and an in-house Advanced Patented Generic pipeline.

All products created with our SPID®-Technology manufacturing approach are patent protected, whether engineered in-house or with an external partner.

Product

2021

2022

2023

2024

2025

LXM.1

Epilepsy

LXM.3

Pain Relief

LXM.2

Diabetes

LXM.5

Parkinson's

LXM.11

Anticoagulant

LXM.16

ADHD

LXM.16

ADHD

External Programs

In-house Programs

Product Registration

Product Launch

Analytical Testing

Clinical Testing

Initial Test Printing

Laxxon - [screen printing (white)].png

Product Pipeline

Learn more about our internal and external pipelines

Wide array of Laxxon's 3D printed tablets

Laxxon has both an external pipeline and an in-house Advanced Patented Generic pipeline.

All products created with our SPID®-Technology manufacturing approach are patent protected, whether engineered in-house or with an external partner.

External Programs

In-house Programs

Initial Test Printing

Analytical Testing

Clinical Testing

Product Registration

Product Launch

Laxxon Medical is disrupting the current pharmaceutical drug delivery and manufacturing landscape through our innovative, patented SPID®-Technology (Screen Printing Innovational Drug Technology).

Stay
Informed

Subscribe for updates on our latest developments.

Thanks for submitting!

Contact Us

We're always eager to chat with potential investors and industry partners. Contact us for any additional information you need.

Thanks for submitting!

All Rights Reserved © 2022 by Laxxon Medical

  • Twitter
  • LinkedIn

135 E 57th Street,

New York, New York 10022

Contact Us

We're always eager to chat with potential investors and industry partners. Contact us for any additional information you need.